SEC 13F Intelligence

Managers / Q4 2023 · view latest →

KENNEDY LEWIS MANAGEMENT LP

CIK 0001797633 · 225 LIBERTY STREET, SUITE 4210, NEW YORK, NY, 10281 · 212-782-3480

Reported Value
$18M
Q4 2023
Positions
5
Filings on Record
12
2022–present window
Filed
Feb 14, 2024
original filing

Summary

Kennedy Lewis Management LP reported $18M in U.S.-listed holdings across 5 positions for Q4 2023.

The portfolio is heavily concentrated: KODK alone accounts for 79.6% of reported value.

Compared with Q3 2023, the fund opened 0 new positions and exited 2.

Portfolio Metrics

Turnover
0.0%
vs prior filed quarter
Largest Position
+79.6%
Eastman Kodak

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $150MQ4 ’21Q1 ’22: $161MQ2 ’22: $91MQ2 ’22Q3 ’22: $88MQ4 ’22: $66MQ4 ’22Q1 ’23: $38MQ2 ’23: $29MQ2 ’23Q3 ’23: $21MQ4 ’23: $18MQ4 ’23Q1 ’24: $23MQ2 ’24: $23MQ2 ’24Q3 ’24: $22Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 99.9%Other: 0.1%
  • Common Stock · 99.9% · $18M
  • Other · 0.1% · $22,366

Quarter-over-Quarter Changes full breakdown →

vs Q3 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
FAST ACQUISITION CORP IISOLD OUT54.2K0$27,088$0
DISRUPTIVE ACQUISITION CORPSOLD OUT83.3K0$3,933$0
RPIDRAPID MICRO BIOSYSTEMS INCHELD+04.94M$2M$4M
KODKEASTMAN KODAK COHELD+03.68M$1M$14M
CHURCHILL CAPITAL CORP VIIHELD+040.3K$7,173$5,246
POLESTAR AUTOMOTIVE HLDG UKHELD+040.0K$5,603$9,605
RCF ACQUISITION CORPHELD+0150.0K$3,345$7,515

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2023

5 positions
#IssuerClass% PortfolioValueShares
1KODKEASTMAN KODAK COhistory →COM NEW79.62%$14M3.68M
2RPIDRAPID MICRO BIOSYSTEMS INChistory →CLASS A COM20.25%$4M4.94M
3POLESTAR AUTOMOTIVE HLDG UKADS C-10.05%$9,60540.0K
4RCF ACQUISITION CORP*W EXP 99/99/9990.04%$7,515150.0K
5CHURCHILL CAPITAL CORP VII*W EXP 02/29/2020.03%$5,24640.3K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2024$22M6Oct 18, 202413F-HRchanges · EDGAR ↗
Q2 2024$23M7Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$23M8Apr 30, 202413F-HRchanges · EDGAR ↗
Q4 2023$18M5Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$21M7Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$29M11Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$38M12May 10, 202313F-HRchanges · EDGAR ↗
Q4 2022$66M15Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$88M20Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$91M20Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$161M20May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$150M29Feb 11, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.